Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - KP-1461

  • Nonsuppressive Drug Therapy for HIV
    increased by administering KP-1461, a drug being developed by Koronis Pharmaceuticals. ... of the clinical trial findings and how a drug such as KP-1461 goes about doing its job. ...
    2-22-2011
  • Need for Novel Approaches to Treating HIV Still Exists
    ... Koronis' lead drug candidate, KP-1461, is a nucleoside that can reportedly accelerate HIV ... we seen any known resistance to standard antiviral drugs due to KP-1461," Parkins states. ...
    7-31-2009
  • NOVEL STRATEGY FOR TREATMENT OF HIV AND OTHER VIRAL INFECTIONS
    Becker also offers an update on Koronis' lead product, KP-1461 in HIV patients, and provides details on research that makes him optimistic that this is a promising approach. He ...
    10-4-2007

  • Journal Articles

  • Safety, Tolerability, and Efficacy of KP-1461 as Monotherapy...
    Charles Hicks, Patrick Clay, Robert Redfield, Jay Lalezari, Ralph Liporace, Stefan Schneider, Michael Sension, MaryPeace McRae, Jean-Pierre Laurent
    AIDS Research and Human Retroviruses
    Safety, Tolerability, and Efficacy of KP-1461 as Monotherapy for 124 Days in ... One such drug, KP-1461, was tested in a population of HIV-infected persons not receiving ...
  • Safety, Tolerability, and Efficacy of KP-1461 as Monotherapy...
    Charles Hicks, Patrick Clay, Robert Redfield, Jay Lalezari, Ralph Liporace, Stefan Schneider, Michael Sension, MaryPeace McRae, Jean-Pierre Laurent, Jacob P Lalezari
    AIDS Research and Human Retroviruses
    Safety, Tolerability, and Efficacy of KP-1461 as Monotherapy for 124 Days in ... One such drug, KP-1461, was tested in a population of HIV-infected persons not receiving ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Top Paid Women in Biopharma

Do you think the women on our list of the 20 top paid women executives in biopharma are underpaid?

Suggest a Poll